Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target

被引：2
|
作者：
Ma, Haodong [1 ]
Ren, Shengju [1 ]
Meng, Qingpeng [1 ]
Su, Boyuan [1 ]
Wang, Kun [1 ]
Liu, YiChen [1 ]
Wang, Junpeng [2 ]
Ding, Degang [2 ]
Li, Xin [1 ,3 ,4 ]
机构：
[1] Zhengzhou Univ, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou 450001, Henan, Peoples R China
[2] Zhengzhou Univ Peoples Hosp, Henan Prov Peoples Hosp, Dept Urol, Zhengzhou 450003, Henan, Peoples R China
[3] Zhengzhou Univ, Collaborat Innovat Ctr Henan Prov Canc Chemopreven, Zhengzhou 450001, Henan, Peoples R China
[4] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Henan, Peoples R China
来源：
ARCHIVES OF VIROLOGY | 2023年 / 168卷 / 08期
基金：
中国国家自然科学基金;
关键词：
Tim-3; COVID-19; Immune response; T-CELL EXHAUSTION; BLOCKADE; AUTOIMMUNE; RESPONSES; PD-1; EXPRESSION; APOPTOSIS; RESTORES;
D O I：
10.1007/s00705-023-05842-2
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
T cell immunoglobulin and mucin domain containing protein 3 (Tim-3), an immune checkpoint, is important for maintaining immune tolerance. There is increasing evidence that Tim-3 is aberrantly expressed in patients with COVID-19, indicating that it may play an important role in COVID-19. In this review, we discuss the altered expression and potential role of Tim-3 in COVID-19. The expression of Tim-3 and its soluble form (sTim-3) has been found to be upregulated in COVID-19 patients. The levels of Tim-3 on T cells and circulating sTim-3 have been shown to be associated with the severity of COVID-19, suggesting that this protein could be a potential biomarker of COVID-19. Moreover, this review also highlights the potential of Tim-3 as a therapeutic target of COVID-19.
引用
收藏
页数：8
相关论文
共 50 条
  • [21] Can GPR4 Be a Potential Therapeutic Target for COVID-19?
    Yang, Li, V
    Oppelt, Karen A.
    Thomassen, Mary Jane
    Marie, Mona A.
    Akhtar, Shayan Nik
    McCallen, Justin D.
    FRONTIERS IN MEDICINE, 2021, 7
  • [22] PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19
    Palma, Giuseppe
    Pasqua, Teresa
    Silvestri, Giovannino
    Rocca, Carmine
    Gualtieri, Paola
    Barbieri, Antonio
    De Bartolo, Anna
    De Lorenzo, Antonino
    Angelone, Tommaso
    Avolio, Ennio
    Botti, Gerardo
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [23] TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma
    Valente, Sofia
    Nascimento, Catarina
    Gameiro, Andreia
    Ferreira, Joao
    Correia, Jorge
    Ferreira, Fernando
    CANCERS, 2023, 15 (02)
  • [24] Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
    Ge, Wenhui
    Li, Jing
    Fan, Wenhao
    Xu, Delong
    Sun, Shangfei
    TUMOR BIOLOGY, 2017, 39 (07) : 1 - 8
  • [25] Transcription factor Nrf2 as a potential therapeutic target for COVID-19
    Wang, Yifan
    Ma, Jing
    Jiang, Yongfang
    CELL STRESS & CHAPERONES, 2023, 28 (01) : 11 - 20
  • [26] Macrophages Potential Therapeutic Target of Myocardial Injury in COVID-19
    Nishiga, Masataka
    Wu, Joseph C.
    CIRCULATION RESEARCH, 2021, 129 (01) : 47 - 49
  • [27] NITRIC OXIDE PATHWAY AS A POTENTIAL THERAPEUTIC TARGET IN COVID-19
    Alkharfy, Khalid M.
    Rehman, Muneeb U.
    Ahmad, Ajaz
    FARMACIA, 2020, 68 (06) : 966 - 969
  • [28] Targeting TIM-3 in solid tumors: innovations in the preclinical and translational realm and therapeutic potential
    Saleh, Reem
    Toor, Salman M.
    Elkord, Eyad
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (12) : 1251 - 1262
  • [29] Hypothesis: The potential therapeutic role of nicorandil in COVID-19
    Ashour, Hend
    Elsayed, Mohamed H.
    Elmorsy, Soha
    Harb, Inas A.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (11) : 1791 - 1797
  • [30] Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases
    Bailly, Christian
    Thuru, Xavier
    Goossens, Laurence
    Goossens, Jean-Francois
    BIOCHEMICAL PHARMACOLOGY, 2023, 209
12345